378 related articles for article (PubMed ID: 27094904)
1. A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.
Chan JF; Lau SK; Wong SC; To KK; So SY; Leung SS; Chan SM; Pang CM; Xiao C; Hung IF; Cheng VC; Yuen KY; Woo PC
Emerg Microbes Infect; 2016 Apr; 5(4):e37. PubMed ID: 27094904
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of chronic pulmonary aspergillosis.
Ohba H; Miwa S; Shirai M; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
Respir Med; 2012 May; 106(5):724-9. PubMed ID: 22349065
[TBL] [Abstract][Full Text] [Related]
3. Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.
Yu Q; He J; Xing B; Li X; Qian H; Zhang H; Xu M; Peng H
BMC Pulm Med; 2020 Apr; 20(1):89. PubMed ID: 32293386
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of
Takazono T; Ito Y; Tashiro M; Nishimura K; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842231
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.
Niu Y; Li J; Shui W; Li D; Yu C; Fu X; Zhang C
J Mycol Med; 2020 Dec; 30(4):101041. PubMed ID: 32950379
[TBL] [Abstract][Full Text] [Related]
6. [Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].
Ehret N; Carlier N; Marey J; Rabbat A; Burgel PR; Roche N
Rev Mal Respir; 2020 Apr; 37(4):308-319. PubMed ID: 32284206
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.
Ohara S; Tazawa Y; Tanai C; Tanaka Y; Noda H; Horiuchi H; Usui K
Respir Investig; 2016 Mar; 54(2):92-7. PubMed ID: 26879478
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of pulmonary aspergillosis.
Kanj A; Abdallah N; Soubani AO
Respir Med; 2018 Aug; 141():121-131. PubMed ID: 30053957
[TBL] [Abstract][Full Text] [Related]
10. Detection of
Ye F; Zeng P; Li Z; Tang C; Liu W; Su D; Zhan Y; Li S
Ann Clin Lab Sci; 2021 Sep; 51(5):698-704. PubMed ID: 34686513
[TBL] [Abstract][Full Text] [Related]
11. Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
Shirai T; Furuuchi K; Fujiwara K; Nakamoto K; Tanaka Y; Ishii H; Yoshiyama T; Yoshimori K; Takizawa H; Sasaki Y; Kurashima A; Ohta K; Morimoto K
Respir Med; 2020 May; 166():105955. PubMed ID: 32321630
[TBL] [Abstract][Full Text] [Related]
12. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
13. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA).
Page ID; Richardson MD; Denning DW
J Infect; 2016 Feb; 72(2):240-9. PubMed ID: 26680697
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.
Izumikawa K; Yamamoto Y; Mihara T; Takazono T; Morinaga Y; Kurihara S; Nakamura S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yanagihara K; Mine M; Yasuoka A; Tashiro T; Kohno S
Med Mycol; 2012 Nov; 50(8):811-7. PubMed ID: 22568603
[TBL] [Abstract][Full Text] [Related]
15. [Aspergillus in airway material : Ignore or treat?].
Salzer HJF; Lange C; Hönigl M
Internist (Berl); 2017 Nov; 58(11):1150-1162. PubMed ID: 28986661
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
17. Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.
Aguilar-Company J; Martín MT; Goterris-Bonet L; Martinez-Marti A; Sampol J; Roldán E; Almirante B; Ruiz-Camps I
Mycoses; 2019 Sep; 62(9):765-772. PubMed ID: 31162731
[TBL] [Abstract][Full Text] [Related]
18. Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan.
Sun KS; Tsai CF; Chen SC; Chen YY; Huang WC
PLoS One; 2016; 11(2):e0149964. PubMed ID: 26900697
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.
Hedayati MT; Azimi Y; Droudinia A; Mousavi B; Khalilian A; Hedayati N; Denning DW
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1759-65. PubMed ID: 26003310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
